Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Editorial Picks · page 13
- Hemp Industry
Plans to Ban Intoxicating Hemp Take Center Stage in Battle to Reopen US Government
The long-running battle over the future of the US hemp industry has become an unlikely flashpoint in efforts to end the longest government shutdown in history.
- Industry Trends
Why Cannabis Stocks Are So Volatile: How Policy, Capital and Hype Shaped a Perpetual Rollercoaster
From the euphoric highs of 2018’s ‘green rush’ to the sharp corrections and structural stasis that have followed, cannabis equities have been among the most volatile financial assets since they first appeared on global markets.
- Medical Cannabis
Cannabis Group Cannim Collapses: UK Clinics Pause, Creditors Pursue Millions
Cannim Group Pty, the international medical cannabis company with operations spanning the UK, Australia, the US and Canada, has entered voluntary administration.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Prescribers & Clinics
High-THC Leads Growth as Australia Tightens TGA Prescribing Rules
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of maturation, regulatory recalibration, and expanding export ambitions, according to new data.
- Hemp Industry
What the US Government Shutdown Means for Cannabis Reform
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown, a move that would eliminate the long-standing 60-vote filibuster rule and allow other legislation to pass by a simple majority.
- UK & Europe
What Will ‘Czech Trump’ Mean for the Country’s Cannabis Industry?
The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a period of political transition following its parliamentary election earlier this month.
- Industry Trends
Speculation to Selectivity: Renewed Optimism Emerges Across Cannabis and Biotech Plays
Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely by last week’s fervent speculation over the President’s social media posts.
- UK & Europe
Spain Becomes Latest European Medical Cannabis Market as First National Rules Given Green Light
First published on Cannabis Health In a landmark decision, Spain’s Council of Ministers has approved a Royal Decree regulating the medical use of cannabis-based preparations in hospital settings, marking the country’s first comprehensive framework for cannabis-derived medicines.
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
- Retail & Brands
Are Rival’s Challenges to High Tide’s German Entry About Compliance Or Competition?
Last month, one of Canada’s largest cannabis retailers, High Tide, thrust its way into the booming German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH in a deal worth over €27m.
- Legal Analysis
How Has the UK Government’s Position on Cannabis Changed Under Labour?
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
